For someone living with a rare disease, being heard can sometimes be just as important as being treated.
The rare disease journey can involve years of searching for a diagnosis, consultations with multiple specialists, complex medical information, difficult treatment decisions and challenges in accessing appropriate care. Even after receiving a diagnosis, patients and caregivers may still have questions about treatment, support, research, financial assistance and what the future may look like.
This is where patient advocacy becomes important.
Patient advocacy is about making sure that the experiences, needs and rights of people living with a disease are understood and considered�in healthcare, research, policymaking and society.
For rare diseases, this voice can be particularly important because individual conditions affect relatively small numbers of people, and the available knowledge, services and resources may be limited.
What is patient advocacy?
Patient advocacy means supporting patients and families so that their needs and experiences are represented and understood.
It can take many forms.
A patient advocate might help a family find reliable information, connect with appropriate support resources, prepare questions for a healthcare appointment or understand how to navigate parts of the healthcare system.
At a broader level, advocacy organizations may work to improve awareness, encourage research, participate in policy discussions and make sure that the experiences of patients are considered when healthcare decisions are being made.
In other words, advocacy can happen at both the individual and the system level.
It is not about telling a patient what medical decision to make. Instead, good advocacy helps people become better informed and ensures that their experiences are not overlooked.
Why is advocacy especially important in rare diseases?
Rare diseases can present challenges that are difficult to address through the healthcare system alone.
A patient may have a condition that very few healthcare professionals have encountered. Reliable information may be difficult to find. Appropriate specialists may not be available nearby. Treatment options may be limited or difficult to access.
The National Policy for Rare Diseases, 2021, issued by India's Ministry of Health and Family Welfare, recognizes challenges including lack of awareness, difficulties in diagnosis, limited treatment options and the need to strengthen infrastructure and care for people with rare diseases. (mohfw.gov.in)
Patient advocacy can help bring these challenges into public and professional conversations.
1. Advocacy gives patients a voice
One of the most powerful things advocacy can do is make the patient experience visible.
Statistics can tell us how many people are affected by a disease. Medical research can tell us about symptoms and treatment. But patients and caregivers can explain what it is actually like to live with the condition.
They can highlight challenges that may not always appear in a medical record:
Difficulty travelling long distances for specialist appointments
Challenges managing a complex treatment schedule
Impact on education or employment
Caregiver responsibilities
Financial pressures
Social isolation
Lack of awareness among people around them
Difficulties accessing appropriate healthcare services
Organizations such as EURORDIS emphasize meaningful patient involvement in healthcare, research, medicine development and policy, with advocacy informed by the real-life experiences of people living with rare diseases. (eurordis.org)
When these experiences are heard, they can help decision-makers understand what patients actually need.
2. Advocacy can improve awareness
A rare disease may be unfamiliar to the general public�and sometimes even to healthcare professionals who have never encountered it.
Greater awareness can help reduce misunderstanding and stigma.
Patient organizations and advocates can share medically accurate information through awareness campaigns, educational programmes, conferences, social media, community initiatives and public discussions.
But effective awareness is more than simply telling people that a disease exists.
It should help people understand:
What is the condition?
Who can be affected?
What challenges do patients face?
Where can reliable information be found?
Where can patients seek appropriate medical care or support?
The goal is to replace misunderstanding with knowledge and isolation with connection.
3. Advocacy can help patients navigate information
A rare disease diagnosis can produce an overwhelming amount of information.
Patients and caregivers may encounter medical terminology, research papers, treatment options, clinical trials, genetic information and online communities�all at once.
Not all information found online is reliable.
Patient advocacy organizations can help direct families towards credible sources and appropriate support services. For example, NORD maintains a database of patient organizations and resources intended to help individuals and families affected by rare diseases find information and support. (rarediseases.org)
This does not mean an advocacy organization should replace a doctor.
Rather, it can help patients become more informed so that they can have more meaningful conversations with their healthcare team.
4. Advocacy can help highlight gaps in access to care
For rare diseases, access can be a major challenge.
A patient may know what treatment or specialist care is recommended but still face practical barriers such as distance, availability, cost or lack of specialized services.
Advocacy can help identify these gaps and bring them to the attention of healthcare institutions, policymakers and other stakeholders.
This is particularly relevant in India, where the National Policy for Rare Diseases includes measures relating to Centres of Excellence, diagnosis, treatment and support for people living with rare diseases. (rarediseases.mohfw.gov.in)
Advocacy does not guarantee that every requested service or treatment will become available.
Its role is to make unmet needs visible and encourage constructive solutions.
5. Patients can contribute to research
Rare disease research faces a fundamental challenge: there may be relatively few patients with any individual condition.
This makes patient participation particularly valuable.
Patients and caregivers may contribute to research through activities such as natural history studies, patient registries, surveys, clinical trials and other research initiatives.
Patient-generated information can help researchers better understand how a disease affects people over time.
NORD, for example, describes patient-powered natural history studies and registries as ways in which patients and caregivers can help inform and shape rare disease research. (rarediseases.org)
However, participation in research should always be informed and voluntary. Patients should understand what information is being collected, how it may be used and what participation involves before deciding whether to take part.
6. Advocacy can influence the future of treatment development
Developing treatments for rare diseases can be challenging.
There may be limited scientific knowledge, small patient populations and difficulties conducting research and clinical trials.
Patients can contribute an important perspective by explaining what outcomes matter to them.
For example, researchers may measure whether a treatment changes a laboratory value or a clinical measure. Patients may also care about whether they can walk more easily, attend school, work, communicate, sleep better or perform everyday activities.
These perspectives can help researchers understand which outcomes are meaningful to the people who will ultimately use a treatment.
Patient organizations therefore increasingly participate in conversations around research and medicine development. NORD's educational resources specifically highlight the role that patients and advocates can play in rare disease drug development. (learn.rarediseases.org)
7. Advocacy can help shape better policies
Healthcare policies affect patients in very practical ways.
Policies can influence areas such as diagnosis, treatment access, research funding, specialist services, newborn screening, social support and healthcare infrastructure.
Individual patients may find it difficult to communicate their experiences to policymakers.
Collective advocacy can bring together the experiences of many patients and families and present them in a structured way.
This does not mean every advocacy effort will immediately lead to policy change.
Change can take time.
But patient voices can help decision-makers understand where existing systems work�and where important gaps remain.
8. Advocacy creates community
Rare diseases can sometimes feel isolating.
A family may struggle to find someone who understands what they are going through.
Connecting with other patients and caregivers can provide something that medical appointments cannot always provide: the feeling that you are not alone.
Patient communities can help people exchange experiences, discover reliable resources and learn from others who have faced similar challenges.
However, every patient's experience is different. What worked for one person may not be medically appropriate for another.
Support communities should therefore complement�not replace�professional medical care.
What does a good patient advocate do?
Effective advocacy is built on information, empathy and responsibility.
A good patient advocate:
Listens to patients and caregivers.
Respects individual choices and dignity.
Shares reliable, evidence-based information.
Clearly distinguishes information from medical advice.
Helps patients ask informed questions.
Protects patient privacy and confidentiality.
Avoids making promises about treatments or outcomes.
Encourages appropriate professional medical care.
Represents patient needs honestly.
Works constructively with healthcare professionals, researchers, policymakers and other stakeholders.
Most importantly, advocacy should be patient-centred rather than organization-centred.
The focus should remain on improving the lives and experiences of people living with rare diseases.
Patients can be advocates too
You do not need to belong to an organization to be a patient advocate.
A patient or caregiver can contribute simply by sharing accurate information, speaking about their experiences when they feel comfortable, participating in research, supporting awareness campaigns or helping another family find a reliable resource.
Some people may choose to advocate publicly.
Others may prefer to contribute privately through research participation, patient surveys or community support.
There is no single �right� way to advocate.
Every informed voice can contribute to a better understanding of rare diseases.
From individual stories to collective change
Patient advocacy is ultimately about something simple:
making sure that people living with rare diseases are part of the conversation about their own healthcare and their future.
A patient's story can help another family feel less alone.
A caregiver's experience can highlight a gap in the healthcare system.
A patient registry can contribute valuable information for research.
A community campaign can increase public awareness.
A collective patient voice can help inform policy.
None of these changes happens overnight.
But together, they can gradually move rare diseases from the margins of healthcare conversations towards greater awareness, understanding and action.
At Healing Wings Foundation, we believe that patients and caregivers should not simply be recipients of information. They should be heard, respected and meaningfully included in conversations that affect their lives.
Because when patients have a voice, awareness becomes understanding, understanding can lead to action, and action can create change.
Medical Disclaimer
This article is intended for general educational and awareness purposes only. It does not constitute medical advice, diagnosis or treatment and should not be used as a substitute for consultation with a qualified healthcare professional.
Patient advocacy organizations can provide education, support and navigation assistance, but they should not replace medical professionals or make individual treatment decisions on behalf of patients. Patients and caregivers should discuss diagnosis, treatment, genetic testing, clinical trials and other healthcare decisions with appropriately qualified healthcare professionals.
Information about rare diseases, healthcare programmes, research and treatment options can change over time. Readers should verify current information through reliable medical, government and institutional sources.
